snmchepatitis

AcutehepatitisBvirus(HBV)isoneofthemostcommoncausesoffulminanthepatitis,especiallyintheendemicarea....SNMCwereusedfortotal15days.,沒有這個頁面的資訊。,由WCHuang著作·2023·被引用1次—StrongerNeo-MinophagenC(SNMC)hasdemonstratedbenefitsinpatientswithhepatitis.Weaimedtodetermineitsusefulnessinpost-TACE ...,由JChen著作·2014·被引用3次—Objective:TocomparetheefficacyandsafetyofStrongerNeo-MinophagenC(S...

參考資訊如下
中文題目：使用惠立妥, 貝樂克雙線抗病毒藥物合併靜脈注射 ...

Acute hepatitis B virus (HBV) is one of the most common causes of fulminant hepatitis, especially in the endemic area. ... SNMC were used for total 15 days.

NCT04015245

沒有這個頁面的資訊。

Benefits of stronger Neo‐Minophagen C in acute hepatitis ...

由 WC Huang 著作 · 2023 · 被引用 1 次 — Stronger Neo-Minophagen C (SNMC) has demonstrated benefits in patients with hepatitis. We aimed to determine its usefulness in post-TACE ...

Efficacy and safety of Stronger Neo

由 J Chen 著作 · 2014 · 被引用 3 次 — Objective: To compare the efficacy and safety of Stronger Neo-Minophagen C (SNMC) in the treatment of chronic hepatitis B. Methods: We searched MEDLINE ...

Long

由 H Kumada 著作 · 2002 · 被引用 259 次 — Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.

Evaluation of Stronger Neo-Minophagen

由 K Reddyvari 著作 · 2015 · 被引用 1 次 — There is increasing evidence to indicate the therapeutic efficacy of SNMC in normalizing liver function tests (LFT) in patients with acute hepatitis. Objectives ...

Therapeutic effects of Stronger Neo

由 L Zhang 著作 · 2000 · 被引用 20 次 — It induces acute and chronic liver disease ranging from chronic hepatitis to hepatocellular carcinoma. So far, interferon is the only one drug used for the ...

Randomized clinical trial with two doses (100 and 40 ml) of ...

由 L Zhang 著作 · 2002 · 被引用 52 次 — Based on these results, SNMC is safe and efficacious in lowering or normalizing ALT levels in patients with chronic hepatitis B in China, and an induction dose ...